ALLMedicine™ Medroxyprogesterone Acetate Injection Center
Research & Reviews 7 results
https://doi.org/10.1016/j.jpag.2018.01.002
Journal of Pediatric and Adolescent Gynecology; Grubb LK, Beyda RM et. al.
Jan 31st, 2018 - To assess the effect of providing standardized counseling to improve the rates of contraception initiation and utilization among detained young women. This was a quality improvement (QI) project conducted at a large urban juvenile short-term deten...
https://doi.org/10.1097/AOG.0000000000001627
Obstetrics and Gynecology; Raymond EG, Weaver MA et. al.
Sep 8th, 2016 - To evaluate the effects of timing of depot medroxyprogesterone acetate injection on medical abortion outcome and risk of repeat pregnancy within the subsequent 6 months. In a multinational randomized trial, we assigned women undergoing medical abo...
https://www.ncbi.nlm.nih.gov/pubmed/26172631
The Journal of Family Practice; Albright M, Rani S et. al.
Jul 14th, 2015 - It depends. Weight doesn't appear to increase with combined oral contraception (OC) compared with nonhormonal contraception, but percent body fat may increase slightly. Depot-medroxyprogesterone acetate injection (DMPA) users experience weight gai...
https://doi.org/10.1016/j.clinthera.2011.02.008
Clinical Therapeutics; Gerlach LS, Saldaña SN et. al.
Mar 14th, 2011 - Depot medroxyprogesterone acetate (DMPA) is an effective (<1% annual failure rate) contraceptive administered by intramuscular injection every 3 months. DMPA is an increasingly popular contraceptive choice for adolescents, yet its use is associate...
https://clinicaltrials.gov/ct2/show/NCT00830414
Jan 26th, 2009 - Criteria for Evaluation: FDA Bioequivalence Criteria Statistical Methods: FDA bioequivalence statistical methods
Drugs 43 results see all →
Clinicaltrials.gov 55 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d415e7cc-0756-4c70-803f-011133a6b731
Feb 17th, 2021 - Medroxyprogesterone Acetate (MPA) Injectable Suspension, USP is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7cff8b17-0468-68ba-e053-2991aa0af484
Feb 16th, 2021 - Medroxyprogesterone acetate is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that oc...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d21979ec-271f-4e4a-8d4d-d561b8a0f563
Jan 18th, 2021 - Medroxyprogesterone Acetate (MPA) Injectable Suspension, USP is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=199cf13e-0859-4a73-9b45-e700d0cd1049
Dec 30th, 2020 - Depo-Provera CI is indicated for use by females of reproductive potential to prevent pregnancy. Depo-Provera CI is a progestin indicated for use by females of reproductive potential to prevent pregnancy. (1) Limitations of Use: The use of Depo-Pro...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908573ce-d494-4f7f-95ae-6edbc4e4c5dc
Dec 29th, 2020 - Medroxyprogesterone acetate injectable suspension for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer t...
